Erythropoietin: Current Status

DSpace/Manakin Repository

Erythropoietin: Current Status

Citable link to this page

 

 
Title: Erythropoietin: Current Status
Author: Bunn, Howard Franklin
Citation: Bunn, Howard Franklin. 1990. Erythropoietin: Current status. Yale Journal of Biology and Medicine 63: 381-386.
Full Text & Related Files:
Abstract: Understanding the regulation of red blood cell production has been greatly enhanced by the cloning and expression of the gene for human erythropoietin (Epo) and its receptor. The availability of recombinant human erythropoietin (rhEpo) for administration to patients has ushered in a new era in molecular medicine. Intravenous or subcutaneous administration of rhEpo can reliably cure the anemia of chronic renal failure and may be effective in the treatment of anemias secondary to chronic inflammation, malignancy, and marrow suppression from chemotherapy. In addition, rhEpo therapy will probably play a prominent role in transfusion medicine, both in preparing patients for auto-transfusions as well as in minimizing red cell transfusion requirements in the post-operative period.
Published Version: http://medicine.yale.edu/yjbm/index.aspx
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2589359/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:8462363
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters